Multivariable predictors for a flare during a drug-free remission period
| OR | 95% CI | |
|---|---|---|
| Anti-CCP positive | 7.5 | 2.9 to 19.4 |
| Weighted mean DAS44 until remission | 4.7 | 1.5 to 15.2 |
| Baseline HAQ | 0.41 | 0.19 to 0.88 |
| Last DMARD | ||
| MTX | Reference | Reference |
| SSA | 3.5 | 1.5 to 15.2 |
| Other | NA | NA |
anti-CCP, anti-cyclic citrullinated peptide; DAS44, disease activity score (44 joints); DMARD, disease-modifying antirheumatic drug; HAQ, health assessment questionnaire; MTX, methotrexate; NA, not applicable due to low patient numbers; SSA, sulfasalazine.